Filing Details
- Accession Number:
- 0001209191-23-004082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-19 18:16:54
- Reporting Period:
- 2023-01-18
- Accepted Time:
- 2023-01-19 18:16:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755662 | Michael David Clark | 3675 Market Street Philadelphia PA 19104 | Chief People Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-18 | 7,382 | $13.50 | 241,067 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
